MLLT11/AF1q boosts oncogenic STAT3 activity through <i>Src</i>-PDGFR tyrosine kinase signaling

Jino Park(University of Louisville), William Tse(University of Louisville)

Oncotarget

June 1, 2016

10.18632/oncotarget.9759

Cited by 31

Related Papers

AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis

|Oncotarget|2015|40

Clofarabine In Combination with Cyclophosphamide for Treatment of Relapsed/Refractory Acute Leukemia In Adult Patients

|Blood|2010|1

In Vivo T-Cell Depletion (TCD) Does Not Improve Rates of Graft-Versus-Host Disease (GVHD) and Transplantation Outcomes in Patients Undergoing Peripheral Blood Allogeneic Hematopoietic Cell Transplant (AHCT)

|Transplantation and Cellular Therapy|2011|0

High Rates of Non-Relapse Mortality and Graft-Versus-Host Disease in Patient Undergoing Allogeneic Stem Cell Transplantation (ASCT) Following Non-Myeloablative (NMA) Conditioning With TLI/ATG

|Transplantation and Cellular Therapy|2011|0

In Vivo T-Cell Depletion Does Not Improve Rates of Graft-Versus-Host Disease and Transplantation Outcomes In Patients Undergoing Peripheral Blood Hematopoietic Cell Transplant.

|Blood|2010|0